Evid Invest
Who owns CRVSWhat CRVS owns — n/a

Who owns Corvus Pharmaceuticals, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of CRVS from SEC Form 13F filings across 177 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 177 institutions disclosed 68.8M shares of Corvus Pharmaceuticals, Inc. worth $792.4M — about 74.4% of shares outstanding; the largest disclosed holder is ORBIMED ADVISORS LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

177

13F holders

$792.4M

value, 2026 filers

74.4%

of shares outstanding (68.8M sh)

26

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of CRVS's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1ORBIMED ADVISORS LLC7.2M$82.5M1.5%7.7%0.0%
2BlackRock, Inc.7.1M$81.8M0.0%7.7%-0.5%
3STATE STREET CORP3.3M$38.4M0.0%3.6%-25.5%
4VANGUARD CAPITAL MANAGEMENT LLC3.3M$38.2M0.0%3.6%+0.8%
5Hood River Capital Management LLC3.3M$38.2M0.3%3.6%+110.8%
6ADAMS STREET PARTNERS LLC3.3M$37.7M11.0%3.5%0.0%
7PRICE T ROWE ASSOCIATES INC /MD/3.1M$35.2M0.0%3.3%-19.3%
8WELLINGTON MANAGEMENT GROUP LLP2.9M$32.9M0.0%3.1%+4.4%
9Vivo Capital, LLC2.8M$32.3M3.6%3%0.0%
10PERCEPTIVE ADVISORS LLC2.5M$28.9M0.5%2.7%-5.9%
11Deep Track Capital, LP2.5M$28.7M0.5%2.7%0.0%
12BRAIDWELL LP1.9M$22.2M0.9%2.1%-9.2%
13Foresite Capital Management VI LLC1.8M$21.1M3.7%2%0.0%
14GEODE CAPITAL MANAGEMENT, LLC1.8M$20.7M0.0%1.9%-3.0%
15Fisher Asset Management, LLCNEW1.0M$12.0M0.0%1.1%new
16Catalio Capital Management, LP1.0M$11.8M2.2%1.1%-5.5%
17MORGAN STANLEY792,714$9.1M0.0%0.9%-41.1%
18VANGUARD PORTFOLIO MANAGEMENT LLC787,558$9.1M0.0%0.9%-3.3%
19ADAGE CAPITAL PARTNERS GP, L.L.C.750,000$8.6M0.0%0.8%0.0%
20TWO SIGMA INVESTMENTS, LP708,566$8.2M0.0%0.8%-9.8%
21EMERALD ADVISERS, LLC680,016$7.8M0.2%0.7%-0.8%
22GOLDMAN SACHS GROUP INC647,024$7.5M0.0%0.7%-59.0%
23CHARLES SCHWAB INVESTMENT MANAGEMENT INC642,526$7.4M0.0%0.7%+208.7%
24DCF Advisers, LLC641,500$7.4M1.7%0.7%+0.6%
25MILLENNIUM MANAGEMENT LLC605,644$7.0M0.0%0.7%-42.2%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.